Drug combinations for malaria: time to ACT? (Q44728447)

5 December 2017

Drug combinations for malaria: time to ACT? (English)

1 reference

5 December 2017

0 references

1

Patrick E Duffy

1 reference

5 December 2017

Theonest K Mutabingwa

series ordinal

2

1 reference

PubMed ID

14723982

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

363

1 reference

5 December 2017

9402

1 reference

5 December 2017

3-4

1 reference

Qinghaosu (artemisinin): an antimalarial drug from China

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915230-0

7 January 2021

Treatment of Malaria in Vietnam with Oral Artemisinin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915230-0

7 January 2021

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915230-0

7 January 2021

Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915230-0

7 January 2021

Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915230-0

7 January 2021

The efficacy of antimalarial monotherapies, sulphadoxine–pyrimethamine and amodiaquine in East Africa: implications for sub‐regional policy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915230-0

7 January 2021

10.1016/S0140-6736(03)15230-0

Identifiers

DOI

1 reference

5 December 2017

1 reference

PubMed ID

14723982